Research Question: How effectively can CRISPR-based genome editing of targeted abiotic stress resistance genes improve outcomes in globally important crop plants?
Research on cfDNA reveals that it can be used as a biomarker, or indicator, for diseases with pathologies it directly contributes to, and its potential to be used to identify and monitor ...
Hypothesis: The gene editing technology CRISPR-Cas9 offers a curative treatment for sickle cell disease, targeting the root cause rather than its symptoms.
